(Fernando) F.G. Albuquerque de Almeida MSc
PhD Candidate Erasmus School of Health Policy & Management Health Technology Assessment (HTA)
- Location
- Erasmus University Rotterdam
- Room
- J 8-15
- Telephone
- +31 10 4088578
- albuquerquedealmeida@eshpm.eur.nl
‹ Back to overview
- N.C. Büyükkaramikli, S. de Groot, D. Fayter, R. Wolff, N. Armstrong, L. Stirk, G. Worthy, F.G. Albuquerque de Almeida, J. Kleijnen & M.J. Al (2017). Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal. Pharmacoeconomics (Print). doi: https://doi.org/10.1007/s40273-017-0581-6
PhD Candidate
- University
- Erasmus University Rotterdam
- School
- Erasmus School of Health Policy & Management
- Department
- Health Technology Assessment (HTA)
- Country
- Nederland
- Telephone
- +31 10 4088578
Pharmaceutical Pricing and Market Access
- Title
- Pharmaceutical Pricing and Market Access
- Year
- 2017
- Period
- BLOK5 MH
- Year level
- master (Health Economics, Policy & Law), master (Health Economics, Policy & Law), master (European master Health Economics & Management)
Pharmaceutical Pricing and Market Access
- Title
- Pharmaceutical Pricing and Market Access
- Year
- 2016
- Period
- BLOK5 MH
- Year level
- master (Health Economics, Policy & Law), master (Health Economics, Policy & Law), master (Health Economics, Policy & Law)